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The use of com puted to mog ra phy is in creas ing rap idly and doses are not neg li gi ble es pe cially
when med i cal pro ce dures re quire more than one scan. The pur pose of the pres ent study was
to mea sure doses in an an thro po mor phic Rando phan tom dur ing a stan dard and low dose
com puted to mog ra phy pro to col of the tho rax and to es ti mate risks of ra di a tion in duced can -
cer for adult pa tients that un dergo mul ti ple com puted  to mog ra phy scans of the tho rax.
Thermoluminescent and radiophotoluminescent do sim e ters were used for dose mea sure -
ments. Ra di a tion risks of can cer in ci dence, in the form of life time at trib ut able risk, were es ti -
mated us ing the BEIR VII model. For five ex po sures with the stan dard pro to col mean or gan
doses were 94 mGy (breast), 85 mGy (stom ach), 85 mGy (thy roid), 78 mGy (lung), 52 mGy
(liver), and 16 mGy (co lon). As so ci ated life time at trib ut able risk were found to be up to
0.401 % (401 breast can cers per 100 000 ex posed pa tients) and 0.116 % (116 lung can cers
per 100 000 ex posed pa tients) for fe male and male, re spec tively. A low dose pro to col re duces
doses (and risks) by the av er age fac tor of 5 and there fore the use of a low dose pro to col is rec -
om mended when ever it is medicaly jus ti fied.
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IN TRO DUC TION
Com puted to mog ra phy (CT) is es tab lished as an
es sen tial tool, not only for di ag no sis, but also for fol -
low-up of the dis eases, as an aid in in ter ven tion, for
screen ing and also for im ag ing in ra dio ther apy. Con -
stant in crease in the use of CT to gether with as so ci ated
doses for or gans within a scan vol ume, con sid er ably
larger in com par i son to cor re spond ing con ven tional
ra dio graphs, have fo cused at ten tion also on the po ten -
tial risk of ra di a tion in duced can cer. Ac cord ing to
pres ent ep i de mi o log i cal data the low est dose of pho -
ton ra di a tion for which rea son ably re li able ev i dence of 
in creased can cer risk ex ists is about 10-50 mGy for
sin gle and 50-100 mGy for pro tracted ex po sure [1].
The typ i cal dose to an or gan within a scan vol ume dur -
ing the CT scan is about 10-20 mGy and of ten can be
even higher [2, 3], but when med i cal pro ce dures re -
quire more than one CT scan, cu mu la tive or gan doses
for a short pe riod can be higher than 50 mGy. 
Ra di a tion pro tec tion prin ci ples, as jus ti fi ca tion
and op ti mi sa tion of pro tec tion, in CT are top ics of sci -
en tific and pub lic con cern. The most im por tant prin ci -
ples which have to be fol lowed are ap pro pri ate jus ti fi -
ca tion of ev ery CT scan and op ti mi za tion of all
tech ni cal pa ram e ters in such a way that the im age
qual ity is se cured keep ing the dose and po ten tial risk
as low as pos si ble [4, 5]. It was shown in a pre vi ous
study [6], which was car ried out on 60 pa tients with
lymphoproliferative dis or ders, that a low dose CT
tech nique can be equally ca pa ble of dem on strat ing
mediastinal pa thol ogy for fol low-up of pa tients with
ma lig nant lym pho mas com pared to the stan dard dose
CT tech nique. The co hort in volved a large num ber of
youn ger and mid dle- aged pa tients who were se lected
for the study as re peated CT scans dur ing their life time
are very im por tant. Due to ef fec tive treat ment these
pa tients have a life ex pec tancy sim i lar to the healthy
pop u la tion and there fore the risk of long term ef fects
of ion iz ing ra di a tion as so ci ated with mul ti ple CT
scans has to be con sid ered and min i mized.
The pur pose of the pres ent study was to mea sure
or gan doses in an an thro po mor phic Rando phan tom
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dur ing the stan dard and low dose CT pro to col of the
tho rax and, tak ing into con sid er ation an av er age num -
ber of mul ti ple CT scans re quired for the se lected pop -
u la tion, to es ti mate the life time at trib ut able risk (LAR) 
of can cer in ci dence. In ad di tion, doses on the sur face
of the phan tom dur ing both pro to cols were mea sured
and com pared to the sur face doses mea sured on 60 pa -
tients from the pre vi ous study [6] us ing the same CT
de vice.
MA TE RI ALS AND METH ODS
CT pro to cols
The phan tom study was per formed on a spi ral
SCT 7800TX (Shimatzu, Ja pan) CT unit at the Clin i -
cal Hos pi tal Merkur. The doses were mea sured with
two dif fer ent scan ning CT pro to cols of the tho rax.
The stan dard pro to col was car ried out with ex po sure
set tings of 120 kV, 160 mA, 7 mm slices, 0.8 s/slice
and pitch 1. The pa ram e ters for the low dose pro to col
were cho sen based on the pre vi ous mea sure ments on
a male Rando Alderson phan tom which re sulted in
the larg est dose re duc tion with out com pro mis ing the
im age  qual ity  in flu enced  by  only  one pa ram e ter;
the tube cur rent [6]. The set tings for the low dose pro -
to col in this study were 120 kV, 30 mA, 7 mm slices
0.8 s/slice and pitch 1. The num ber of slices for both
pro to cols was 47. Scan ning  vol ume  was from the
lung api ces to the base. Be fore each ex po sure, a
topogram was made in AP  pro jec tion  with stan dard
ex po sure con di tions of 120 kV and 100 mAs. 
Phan tom
The phan tom used for this study was an an thro -
po mor phic male Rando Alderson Phan tom (175 cm
height, 73.5 kg weight) which con sists of 35 ax ial seg -
ments with a width of 2.5 cm con tain ing a hu man skel -
e ton and tis sue equiv a lent ma te rial. It rep re sents an av -
er age adult pa tient. In side the phan tom do sim e ters are
placed into the holes lo cated on in the po si tions of dif -
fer ent or gans/tis sues.
Do sim e try sys tems
The doses in/on the phan tom were mea sured with
thermoluminescent do sim e ters (TLD), based on LiF:Mg,Ti 
(TLD-100, Thermo Sci en tific) and radiophotoluminescent
(RPL) glass do sim e ters (type GD-352M, Asahi Techno
Glass Cor po ra tion). TLD were made in the form of pel lets
(∅4.5 mm × 0.9 mm). RPL do sim e ters were sil ver ac ti vated 
phos phate glass rods (∅1.5 mm × 12 mm) packed in a plas -
tic holder (outer di men sions: ∅4.3 mm × 14.5 mm) con -
tain ing a tin en ergy com pen sa tion fil ter which en ables their
use for me dium and low en ergy X-rays that are usu ally used 
in di ag nos tic ra di ol ogy. Rel a tive stan dard un cer tainty of the
de ter mined dose for RPL and TLD was re ported as 2.1 % 
and 2.9 %, re spec tively [7]. For RPL, un cer tain ties in clude
re peat abil ity, cal i bra tion and an gu lar cor rec tion, while for
TLD an gu lar cor rec tion is not in cluded be cause an gu lar de -
pend ence is re ported only for RPL [8, 9]. De tailed char ac -
teri sa tion of RPL and TLD are given in pre vi ously pub -
lished pa pers [7, 10, 11]. 
Prior to the mea sure ments for im proved ac cu -
racy for all TLD, in di vid ual sen si tiv ity cor rec tion fac -
tors were cal cu lated by ir ra di at ing all TLD to a uni -
form dose of 5 mGy (kerma „free in air”) us ing the
137Cs source in the Sec ond ary Stan dard Do sim e try
Lab o ra tory (SSDL) at the Rudjer Boškovi} In sti tute
[12]. In case of RPL do sim e ters there was no need for
in di vid ual sen si tiv ity cor rec tions [7, 10]. Cal i bra tions
of RPL and TL de tec tors for in/on phan tom mea sure -
ments were also done us ing the same 137Cs ra di a tion
source and pre vi ously de ter mined cor rec tion fac tors
for do sim e ters ob tained for X-ray spec tra typ i cally
used in CT im ag ing were ap plied. Mea sured doses in
the phan tom were ex pressed as ”ab sorbed dose to wa -
ter” us ing the con ver sion fac tor from kerma ”free in
air” (Kair) to “ab sorbed dose to wa ter” (Dw): Dw/Kair =
=.1.112 [13]. The fi nal re sults of or gan/tis sue doses,
DT, pre sented with stan dard de vi a tions in ta bles and
fig ures and used for risk es ti mates, are cal cu lated as a
mean value of RPL and TLD val ues.
Mea sure ments
A to tal of 58 do sim e ters were placed in side the
phan tom on the se lected or gan po si tions (thy roid,
lung, breast, liver, and co lon) which are de ter mined by
con sult ing an at las of sec tional anat omy. The en trance
sur face dose (ESD) was mea sured dur ing both pro to -
cols on the sur face of the phan tom on the po si tions of
the eye lens, thy roid, breasts and go nads bi lat er ally.
For mea sure ments of doses on the sur face two TLD
(packed in thin dark poly eth yl ene bags) and two RPL
were packed to gether. The fi nal ESD value is cal cu -
lated as a mean value of 4 do sim e ters. In or der to ob -
tain better ac cu racy of dose mea sure ments and tak ing
into con sid er ation an av er age num ber of re quired CT
scans for pa tients with lymphoproliferative dis or ders
dur ing ther apy, five ex po si tions to gether with five
topograms were made in or der to sim u late the con di -
tions the same as it had been done pre vi ously on pa -
tients [6].
Can cer risk es ti mate
Can cer risks, in the form of LAR of can cer in ci -
dence, were es ti mated by ap ply ing the meth ods in tro -
duced in the bi o log i cal ef fects of ion iz ing ra di a tion
M. Majer, et al.: Or gan Doses and As so ci ated Can cer Risks for ...
Nu clear Tech nol ogy & Ra di a tion Pro tec tion: Year 2018, Vol. 33, No. 1, pp. 100-105 101
(BEIR) re port VII [14]. LAR is de fined as the prob a -
bil ity that an ir ra di ated per son could de velop a ra di a -
tion-in duced can cer dur ing their life time. For leu kae -
mia and can cer LAR data are tab u lated for each gen der 
and eleven dis crete ages at of ex po sure in ta ble 12D-1
of the BEIR VII re port as the num ber of can cer cases
per 105 per sons ex posed to a sin gle dose of 100 mGy
[14]. As sum ing a „lin ear no-thresh old” (LNT)
dose-risk re la tion ship, the LAR for mea sured or gan
doses (DT) in this study were cal cu lated with lin ear ex -
trap o la tion of LAR data from BEIR VII ta ble 12D-1.
When nec es sary, lin ear in ter po la tion for age at ex po -
sure was ap plied. To es ti mate the ra di a tion risk for
mul ti ple CT scans as sump tion of risk additivity was
ap plied as sug gested in [14]. As pa tients with
lymphoproliferative dis or ders un dergo mul ti ple tho -
rax CT scans in a short time (usu ally in an in ter val of
3-12 months dur ing 1-2 years), LAR for a sin gle ir ra -
di a tion was mul ti plied by the av er age num ber of CT
scans to ob tain a LAR for mul ti ple ir ra di a tion. 
RE SULTS AND DIS CUS SION
Dose mea sure ments in the phan tom
For each pro to col doses in the phan tom were
mea sured with two types of do sim e ters (TLD and
RPL). With the ex cep tion of do sim e ters in the thy roid
and  co lon,  the  agree ment  be tween two do sim e try
sys tems was sat is fac tory and it was on av er age within
7 %. Un cer tain ties of both types of do sim e ters are be -
low 3 % [8], but in this study they might be higher (es -
pe cially for RPL) as the an gu lar de pend ence un cer -
tainty fac tor used in [8] was es ti mated for a 6 MV
pho ton beam [7] and not for CT con di tions. A pos si ble
ex pla na tion for larger un der/over es ti ma tion by RPL
com pared to TLD in the thy roid and co lon, might be
larger di men sions of RPL do sim e ters in com par i son to
TLD which re sults that for the same hole, close to the
bor der of the scan vol ume, the RPL was pos si ble partly 
in the scan vol ume, while TLD was com pletely in/out. 
For fur ther cal cu la tions mean val ues of TLD and 
RPL val ues were cal cu lated and used.
Com par i son of doses for the stan dard and low
dose CT pro to col mea sured in the phan tom for 5 con -
sec u tive ex po si tions is given in fig. 1. For the stan dard
pro to col, as well as for the low dose pro to col, the high -
est doses were mea sured on the po si tion of the breast
and were 94  ±  4 mGy and 17.2 ± 0.2 mGy, re spec tively.
The mean doses mea sured dur ing the stan dard
pro to col in dif fer ent or gans were on av er age 5 times
(range 4.3-6.1) higher in com par i son to the low dose
pro to col.
Dose mea sure ments on the phan tom and
com par i son with en trance sur face doses
mea sured in the pre vi ous study
on the pa tients
Re sults for en trance sur face doses (ESD) mea -
sured on the phan tom in com par i son with ESD mea -
sured in the pre vi ous study [6] on 60 pa tients with
lymphoproliferative dis or ders for both pro to cols are
shown in tab. 1. All re sults are re lated with only one
CT ex po si tion. Due to large dis si pa tions of the mea -
sured pa tient doses (due to large dif fer ences in size of
pa tients, num ber of slices and im aged vol ume) not
only mean val ues of ESD, but min i mum and max i -
mum val ues are also shown. The an thro po mor phic
phan tom used in this study rep re sents an av er age adult
per son and, as ex pected, phan tom dose val ues shown
in tab. 1 are be tween the min and max pa tient dose val -
ues. 
Dose vari a tions for dif fer ent pa tients are small
for breasts (rel a tive stan dard de vi a tion for both pro to -
cols is 9 %), but for the thy roid they are very prom i nent 
(rel a tive stan dard de vi a tion is 48 % and 28 % for the
stan dard and low dose pro to col re spec tively). The rea -
son for those dif fer ences in dose vari a tions is that dur -
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Fig ure 1. Com par i son of mean or gan doses with
stan dard de vi a tions for 5 ex po sures mea sured in the
Rando phan tom dur ing the stan dard and low dose CT
pro to col; error bars in the fig ure show the stan dard
de vi a tion of mea sured dose val ues within each or gan
Ta ble 1. Com par i son of ESD mea sured on the phan tom
and on the 60 pa tients for the stan dard (A) and low dose
(B) CT pro to col; both ESD were re lated with a sin gle
ex po si tion
Or gan Pro to col
Pa tients(A ) Phan tom(B)
ESD [mGy] ESD [mGy]
Mean ± SD Min Max Mean ± SD
Lens
A 0.60 ± 0.42 0.12 3.08 0.31 ± 0.07
B 0.11 ± 0.04 0.03 0.21 0.07 ± 0.02
Thy roid
A 16.40 ± 7.92 2.95 30.81 25.1 ± 2.2
B 4.68 ± 1.31 2.81 7.12 4.6 ± 0.8
Breast
A 22.78 ± 2.10 17.44 28.09 20.4 ± 1.9
B 6.31 ± 0.59 3.51 8.80 3.9 ± 0.6
Go nads
A 0.22 ± 0.19 0.05 1.07 0.15 ± 0.01
B 0.10 ± 0.05 0.02 0.35 0.03 ± 0.01
(A) from study [6], (B) this study
ing the CT of the tho rax breasts are com pletely in -
cluded in the scan vol ume while the thy roid is on the
bor der of the scanned re gion and de pend ing on the pa -
tient's anat omy, it can be partly or com pletely ex cluded 
from the scan vol ume. For phan tom mea sure ments the
max i mum scan area was cho sen. For both pro to cols
ESD for the breast mea sured on the phan tom was 10 %
higher than DT for the breast. ESD to DT ra tio for the
breast was 1.1 ± 0.1 and 1.1 ± 0.2 for the stan dard and
low dose pro to col, re spec tively. 
In this study ESD was mea sured for the an thro -
po mor phic phan tom and com pared with ESD val ues
mea sured for the pa tients [6] us ing the same meth od ol -
ogy and two types of RPL and TL do sim e ters.  In lit er -
a ture, Alzimami et al. [15] used TL do sim e ters type
GR-200A to mea sure a pa tient's ESD dur ing con ven -
tional and CT urography but jus ti fi ca tion and un cer -
tainty was not dis cussed. ESD for CT ex am i na tions on
an antropomorphic phan tom was mea sured by
Tsalafoutas et al. [16] but us ing dif fer ent in stru ments
(ac tive solid state de tec tors) in or der to es ti mate the
skin dose.  Tagekami et al. [17] re cently tested a small
op ti cally stim u lated lu mi nes cence (OSL) do sim e ter to
mea sure the ESD when per form ing a CT ex am i na tion
and con cluded that the OSL do sim e ter can be con sid -
ered suit able for mea sur ing the ESD with an un cer -
tainty of 30 % dur ing CT ex am i na tions in which pitch
fac tors be low 1.000 are ap plied.
Can cer risk es ti mate
LAR of de vel op ing ra di a tion-in duced can cer as -
so ci ated with five ex po sures to the stan dard CT pro to -
col for 20 and 56 year old per sons are shown in tab. 2.
The age of 56 was cho sen be cause the av er age pa tient's 
age in the pre vi ous study [6] was 56 years. The av er age 
age of the youn gest group of pa tients was 20. The av -
er age num ber of re quired CT ex am i na tions was as -
sumed to be five. In tab. 2 only the re sults for the stan -
dard CT pro to col are pre sented. Low dose pro to col
re duces doses and as so ci ated LAR by the av er age fac -
tor of 5. The re verse or der for breast and lung for a 56
year old fe male pa tient com pared to a 20 year old fe -
male pa tient is due to the fact that lung can cer risk does 
not de crease with in creas ing age at ex po sure. More -
over, ex cess rel a tive risk (ERR) for lung can cer has a
max i mum when age at ex po sure is around 55 years
[18]. 
In lit er a ture there are many stud ies deal ing with
can cer risk as so ci ated with CT ex am i na tions. In the
ma jor ity of the stud ies the ra di a tion in duced risk is cal -
cu lated by means of an es ti mate of or gan and ef fec tive
doses us ing the com puted to mog ra phy dose in dex
(CTDI) val ues and/or on the ba sis of Monte Carlo cal -
cu la tions and math e mat i cal phan toms [19-23]. The
ad van tage of dose mea sure ments in the phan tom is the
di rect mea sure ment of doses in the po si tions of sen si -
tive or gans or tis sues which are in dis pens able to es ti -
mate risk for par tic u lar can cers. Also some stud ies re -
ported that com pared with di rect TLD mea sure ments,
com puter sim u lated tech niques are likely to un der es ti -
mate the dose [24, 25]. 
Can cer risk es ti mates in this study have been
made us ing BEIR VII meth ods as sum ing a lin ear
dose-risk re la tion ship and def i ni tion of LAR. Lim i ta -
tions and un cer tain ties [20, 26] of can cer risk mod els is
an im por tant is sue; con tro versy con cern ing the use of
the LNT model for low doses and low dose rates [27,
28] should be also men tioned, but this dis cus sion is be -
yond the scope of this pa per. How ever, most of the
doses in this study are above the very del i cate re gion be -
low 10 mGy (where the ra di a tion-can cer re la tion ship is
not clear) and it was as sumed as rea son able to con sider
the LNT model (as sug gested by stan dard bod ies) [4,
14, 29, 30]. Nev er the less, the mea sured doses are valu -
able in for ma tion and it is al ways rea son able to con sider
dose re duc tion if it is med i cally jus ti fied es pe cially in
pa tients that re quire mul ti ple ir ra di a tions which con se -
quently lead to a higher cu mu la tive dose.
CON CLU SION
The  high est  or gan  doses  dur ing  the  sin gle
stan dard  CT  pro to col  of  the tho rax were mea sured
for the breast (18.8 mGy), stom ach (17 mGy), thy roid
(17 mGy) and lung (15.6 mGy). As sum ing that the av -
er age num ber of CT scans for pa tients with
lymphoproliferative dis or ders is five (dur ing 1-2
years), as so ci ated LAR for the stan dard dose CT pro -
to col were found to be up to 0.401 % for fe male and
0.116 % for male. Com par i son of the re sults for the
stan dard and low dose pro to col showed that the low
dose pro to col yielded with the re duc tion of or gan
doses (and risks) by the av er age fac tor of 5 (5.1 ± 0.7). 
As the low dose CT tech nique can be equally ca pa ble
of dem on strat ing mediastinal pa thol ogy for fol low-up
of this group of pa tients as pre vi ously shown in [6], the 
use of the low dose pro to col is highly rec om mended as 
an al ter na tive in rou tine clin i cal prac tice. 
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Ta ble 2. LAR of de vel op ing ra di a tion-in duced can cer
as so ci ated with five ex po sures us ing the stan dard CT
pro to col for 20 and 56 year old per sons; DT is the or gan




20 years 56 years
Male Fe male Male Fe male
Thy roid 85 18 96 1 2
Lung 78 116 270 73 166
Breast 94 – 401 – 44
Liver 52 12 5 6 3
Stom ach 85 34 46 19 25
Co lon 16 28 18 16 11
(a) Num ber of can cer cases per 105 ex posed per sons
AU THORS' CON TRI BU TIONS
The manu script was writ ten by M. Majer, Ž.
Kneževi}, and S. Miljani}. J. Popi} and H. Hršak were
re spon si ble for CT ir ra di a tions and the re la tion ship
be tween the do sim e ter's po si tions in the phan tom and
the par tic u lar or gan. M. Majer and Ž. Kneževi} were
re spon si ble for do sim e try and data anal y sis. The can -
cer risk es ti mate was pre pared by M. Majer. Re sults
were dis cussed by all au thors. The fig ures and ta bles
were pre pared by M. Majer. 
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DOZE  U  ORGANIMA  I  PRIDRU@ENI  RIZIK  KARCINOMA
PRI  ISPITIVAWU  GRUDNOG  KO[A  KOMPJUTERSKOM  TOMOGRAFIJOM
Upotreba kompjuterske tomografije je u velikom porastu, a doze nisu zanemarive
pogotovo ako medicinska procedura zahteva vi{e od jednog snimawa. Ciq ovog rada bio je da se
izmere doze u antropomorfnom fantomu Rando tokom snimawa grudnog ko{a kompjuterskom
tomografijom primenom standardnog i niskodoznog protokola, kao i procena rizika za oboqevawe 
od karcinoma nakon zra~ewa za odrasle bolesnike koji prolaze nekoliko snimawa grudnog ko{a.
Doze su merene termoluminescentnim i radiofotoluminiscentnim dozimetrima. Rizici za pojavu
karcinoma, u obliku `ivotnog rizika za obolevawe od karcinoma, proceweni su kori{}ewem
modela  BEIR  VII.  Za  pet  snimawa  standarnim  protokolom,  sredwe  doze  u  organima  iznosile  su
94 mGy (grudi), 85 mGy (trbuh), 85 mGy ({titwa~a), 78 mGy (plu}a), 52 mGy (jetra), i 16 mGy (debelo
crevo). Odgovaraju}i ` ivotni rizici za obolevawe od karcinoma iznosili su najvi{e 0.401 % (401
karcinom grudi na 100 000 ozra~enih bolesnika) i 0.116 % (116 karcinoma plu}a na 100 000
ozra~enih bolesnika) za `ene, odnosno mu{karce. Upotreba niskodoznog protokola smawila je
doze (i rizike) u proseku za pet puta i stoga se upotreba niskodoznog protokola preporu~uje  kad god 
je medicinski opravdana.
Kqu~ne re~i: doza organa, rizik radijacionog kancera, kompjuterska tomografija, grudni ko{,
..........................protokol niskih doza
